Literature DB >> 12807865

Calcific aortic stenosis: from bench to the bedside--emerging clinical and cellular concepts.

Nalini M Rajamannan1, Bernard Gersh, Robert O Bonow.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12807865      PMCID： PMC1767746          DOI： 10.1136/heart.89.7.801

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  22 in total

1.  Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons.

Authors:  W S Aronow; C Ahn; I Kronzon; M E Goldman
Journal:  Am J Cardiol       Date:  2001-09-15       Impact factor: 2.778

2.  New insights into the progression of aortic stenosis: implications for secondary prevention.

Authors:  S Palta; A M Pai; K S Gill; R G Pai
Journal:  Circulation       Date:  2000-05-30       Impact factor: 29.690

3.  Usefulness of electron beam tomography to detect progression of coronary and aortic calcium in middle-aged women.

Authors:  K Sutton-Tyrrell; L H Kuller; D Edmundowicz; A Feldman; R Holubkov; L Givens; K A Matthews
Journal:  Am J Cardiol       Date:  2001-03-01       Impact factor: 2.778

4.  Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis.

Authors:  G M Novaro; I Y Tiong; G L Pearce; M S Lauer; D L Sprecher; B P Griffin
Journal:  Circulation       Date:  2001-10-30       Impact factor: 29.690

5.  Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve.

Authors:  Nalini M Rajamannan; Malayannan Subramaniam; Margaret Springett; Thomas C Sebo; Marek Niekrasz; Joseph P McConnell; Ravinder J Singh; Neil J Stone; Robert O Bonow; Thomas C Spelsberg
Journal:  Circulation       Date:  2002-06-04       Impact factor: 29.690

6.  Electron beam computed tomography for the quantification of aortic valvular calcification.

Authors:  J R Kizer; W B Gefter; A S deLemos; B J Scoll; M L Wolfe; E R Mohler
Journal:  J Heart Valve Dis       Date:  2001-05

7.  HMG CoA reductase inhibitor (statin) and aortic valve calcium.

Authors:  David M Shavelle; Junichuro Takasu; Matthew J Budoff; SongShou Mao; Xue Qiao Zhao; Kevin D O'Brien
Journal:  Lancet       Date:  2002-03-30       Impact factor: 79.321

8.  C-reactive protein is increased in patients with degenerative aortic valvular stenosis.

Authors:  A Galante; A Pietroiusti; M Vellini; P Piccolo; G Possati; M De Bonis; R L Grillo; C Fontana; C Favalli
Journal:  J Am Coll Cardiol       Date:  2001-10       Impact factor: 24.094

9.  Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community.

Authors:  Michael F Bellamy; Patricia A Pellikka; Kyle W Klarich; A Jamil Tajik; Maurice Enriquez-Sarano
Journal:  J Am Coll Cardiol       Date:  2002-11-20       Impact factor: 24.094

10.  Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patients.

Authors:  D L Sprecher; E J Schaefer; K M Kent; R E Gregg; L A Zech; J M Hoeg; B McManus; W C Roberts; H B Brewer
Journal:  Am J Cardiol       Date:  1984-07-01       Impact factor: 2.778
View more
  37 in total

1.  Risk factors for progression of calcific aortic stenosis and potential therapeutic targets.

Authors:  Ashvin R Kamath; Ramdas G Pai
Journal:  Int J Angiol       Date:  2008

2.  Is it time for medical therapy for aortic valve disease?

Authors:  Nalini M Rajamannan
Journal:  Expert Rev Cardiovasc Ther       Date:  2004-11

3.  Impact of coronary artery disease on in-hospital mortality in patients with aortic valve disease. Results from the German ALKK registry.

Authors:  R Höllriegel; A Linke; M Hochadel; G Schuler; S Kerber; R Hambrecht; E Grube; K E Hauptmann; R Zahn; U Zeymer; J Senges
Journal:  Herz       Date:  2013-01-18       Impact factor: 1.443

Review 4.  Role of angiogenetic factors in cardiac valve homeostasis and disease.

Authors:  Daihiko Hakuno; Naritaka Kimura; Masatoyo Yoshioka; Keiichi Fukuda
Journal:  J Cardiovasc Transl Res       Date:  2011-08-25       Impact factor: 4.132

5.  Mechanism Underlying the Effects of Estrogen Deficiency on Otoconia.

Authors:  Liping Yang; Yinfang Xu; Yan Zhang; Sarath Vijayakumar; Sherri M Jones; Yunxia Yesha Wang Lundberg
Journal:  J Assoc Res Otolaryngol       Date:  2018-04-23

6.  Endothelial nitric oxide signaling regulates Notch1 in aortic valve disease.

Authors:  Kevin Bosse; Chetan P Hans; Ning Zhao; Sara N Koenig; Nianyuan Huang; Anuradha Guggilam; Stephanie LaHaye; Ge Tao; Pamela A Lucchesi; Joy Lincoln; Brenda Lilly; Vidu Garg
Journal:  J Mol Cell Cardiol       Date:  2013-04-11       Impact factor: 5.000

7.  Reduced EGFR causes abnormal valvular differentiation leading to calcific aortic stenosis and left ventricular hypertrophy in C57BL/6J but not 129S1/SvImJ mice.

Authors:  Cordelia J Barrick; Reade B Roberts; Mauricio Rojas; Nalini M Rajamannan; Carolyn B Suitt; Kevin D O'Brien; Susan S Smyth; David W Threadgill
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-15       Impact factor: 4.733

Review 8.  Molecular mechanisms underlying the onset of degenerative aortic valve disease.

Authors:  Daihiko Hakuno; Naritaka Kimura; Masatoyo Yoshioka; Keiichi Fukuda
Journal:  J Mol Med (Berl)       Date:  2008-09-03       Impact factor: 4.599

9.  Cross-talk between the Toll-like receptor 4 and Notch1 pathways augments the inflammatory response in the interstitial cells of stenotic human aortic valves.

Authors:  Qingchun Zeng; Chunhua Jin; Lihua Ao; Joseph C Cleveland; Rui Song; Dingli Xu; David A Fullerton; Xianzhong Meng
Journal:  Circulation       Date:  2012-09-11       Impact factor: 29.690

10.  Increased dietary intake of vitamin A promotes aortic valve calcification in vivo.

Authors:  Danielle J Huk; Harriet L Hammond; Hiroyuki Kegechika; Joy Lincoln
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11-29       Impact factor: 8.311
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.